Crossingbridge Advisors, LLC Q4 2025 Filing

Filed February 13, 2026

Portfolio Value

$355.5B

Holdings

105

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (105 positions)

#StockSharesValue% PortfolioType
101
MGTEMARBLEGATE CAPITAL CORP
8,844$20.0M0.01%
102
VRNOVERANO HOLDINGS CORP
12,234$15.0M0.00%
103
ASBPASPIRE BIOPHARMA HOLDINGS INC
24,348$3.0M0.00%
104
ASBPWASPIRE BIOPHARMA HOLDINGS INC WRNT
49,846$00.00%
105
JACSJackson Acquisition Co II
17$00.00%
106
UPHLUPHEALTH INC
533,414$00.00%
PreviousPage 2 of 2